Evidence map›Paper›PMID 34023573›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2021

SARS-CoV-2 RT-PCR positivity and antibody prevalence among asymptomatic hospital-based health care workers.

Christine C Johnson, Chad M Coleman, Alexandra R Sitarik, Joyce E Leon, Robert J Tibbetts, Bernard C Cook, Bruce K Muma, Allison J Weinmann, Linoj P Samuel

Abstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. COVID-19 in the hotspot of Metropolitan Detroit: A multi-faceted health system experience.The International journal of health planning and management · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christine C JohnsonDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, United States. Electronic address: cjohnson1@hfhs.org.
Chad M ColemanDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, United States.
Alexandra R SitarikDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, United States.
Joyce E LeonPopulation Health, Henry Ford Health System, Detroit, MI, United States.
Robert J TibbettsDepartment of Pathology, Henry Ford Health System, Detroit, MI, United States.
Bernard C CookDepartment of Pathology, Henry Ford Health System, Detroit, MI, United States.
Bruce K MumaPopulation Health, Henry Ford Health System, Detroit, MI, United States.
Allison J WeinmannDivision of Infectious Diseases, Department of Medicine, Henry Ford Health System, Detroit, MI, United States.
Linoj P SamuelDepartment of Pathology, Henry Ford Health System, Detroit, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe level of asymptomatic infection with SARS-CoV-2 could be substantial and among health care workers (HCWs) a source of continuing transmission of the virus to patients and co-workers.

objectivesMeasure the period prevalence of SARS-CoV-2 PCR positivity and seroprevalence of SARS-CoV-2 IgG antibodies among a random sample of asymptomatic health system hospital-based health care workers (HCWs) 6½ -15½ weeks after 4/5/2020, the peak of the first surge of COVID-19 admissions.

resultsOf 524 eligible and consented participants from four metropolitan hospitals, nasopharyngeal swabs were obtained from 439 (83.8 %) and blood from 374 (71.4 %). Using PCR nucleic acid-based amplification (NAAT) methods, the period prevalence of SARS-CoV-2 infection was 0.23 % (95 % confidence interval (CI) 0.01 %-1.28 %; 1/439) from 5/21/20-7/16/20. The seroprevalence of SARS-CoV-2 IgG antibodies from June 17-July 24, 2020 was 2.41 % (95 % CI 1.27 %-4.51 %; 9/374). Those who were reactive were younger (median age 36 versus 44 years; p = 0.050), and those with self-reported Hispanic/Latino ethnicity had a higher seroprevalence (2/12 = 16.7 % versus 7/352 = 2.0 %; p = 0.051). There were no significant differences by sex, race, residence, hospital, unit or job type. The one employee who was found to be PCR test positive in this study was also reactive for IgG antibodies, tested 27 days later.

conclusionsThe period prevalence of PCR positivity to SARS-CoV-2 and IgG seroprevalence was unexpectedly low in asymptomatic HCWs after a peak in COVID-19 admissions and the establishment of state and institutional infection control policies, suggesting that routine screening tests while community prevalence is relatively low would produce a minimal yield.

Indexed as

Asymptomatic InfectionsCOVID-19Health PersonnelSARS-CoV-2AdultAntibodies, ViralCOVID-19 Nucleic Acid TestingDelivery of Health CareFemaleHospitalsHumansMaleMiddle AgedPrevalenceReverse Transcriptase Polymerase Chain ReactionSeroepidemiologic StudiesAntibodies, ViralHealth care workersPrevalenceSARS-CoV-2

Identifiers

PMID34023573
PMCPMC7962992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.